Health
Drug enhances bone marrow transplant outcomes for leukaemia patients – Health Europa
Experts have identified a drug that reduces the risk of leukaemia recurring when administered in combination with a bone marrow…
A team of researchers from the University of Michigan Health Rogel Cancer Center have ascertained that a treatment known as interferon can lower the risk of leukaemia recurrence in high-risk patients by 20% when given alongside a bone marrow transplant.
…
Continue Reading
